174 related articles for article (PubMed ID: 16453099)
1. [From the molecular genetics of Alport's syndrome to principles of organo-protection in chronic renal diseases].
Gross O; Weber M
Med Klin (Munich); 2005 Dec; 100(12):826-31. PubMed ID: 16453099
[TBL] [Abstract][Full Text] [Related]
2. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
Beirowski B; Weber M; Gross O
J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in hereditary nephritis (Alport's syndrome).
Bubalo FS; Davidson DD
Indiana Med; 1991 Dec; 84(12):860-6. PubMed ID: 1774457
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant Alport's syndrome: study of a large Tunisian family.
Kharrat M; Makni S; Makni K; Kammoun K; Charfeddine K; Azaeiz H; Jarraya F; Ben Hmida M; Gubler MC; Ayadi H; Hachicha J
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):320-5. PubMed ID: 16970251
[TBL] [Abstract][Full Text] [Related]
5. [Thin glomerular basement membrane disease].
Frascà GM; Balestra E; Fanciulli E; Freddi P; Mazzucchelli R; Montironi R; D'Arezzo M; Sagripanti S
G Ital Nefrol; 2008; 25(1):49-56. PubMed ID: 18264918
[TBL] [Abstract][Full Text] [Related]
6. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
Voskarides K; Pierides A; Deltas C
Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
[TBL] [Abstract][Full Text] [Related]
7. Alport's syndrome with focal segmental glomerulosclerosis lesion - Pattern to recognize.
Alsahli AA; Alshahwan SI; Alotaibi AO; Alsaad KO; Aloudah N; Farooqui M; Al Sayyari AA
Saudi J Kidney Dis Transpl; 2018; 29(1):167-172. PubMed ID: 29456224
[TBL] [Abstract][Full Text] [Related]
8. The gene corresponding to the putative Goodpasture antigen is present in Alport's syndrome.
Savige JA
Clin Exp Immunol; 1991 Aug; 85(2):236-9. PubMed ID: 1864003
[TBL] [Abstract][Full Text] [Related]
9. Genetics and CKD.
Vehaskari VM
Adv Chronic Kidney Dis; 2011 Sep; 18(5):317-23. PubMed ID: 21896372
[TBL] [Abstract][Full Text] [Related]
10. Hereditary interstitial nephritis without basement membrane changes.
Levy NT; Meyers AM; Margolius LP; Verhaart S; Wadee WA
Nephron; 1995; 69(4):418-23. PubMed ID: 7777106
[TBL] [Abstract][Full Text] [Related]
11. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
12. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
[TBL] [Abstract][Full Text] [Related]
13. Alport's syndrome.
Bruni V; Petrisano M; Tarsitano F; Falvo F; Parisi F; Cucinotta U; Betta P; Di Benedetto V; Scuderi MG; Pensabene L; Sestito S; Cuppari C; Fede C; Chimenz R; Concolino D
J Biol Regul Homeost Agents; 2019; 33(5 Suppl. 1):19-24. Special Issue: Focus on Pediatric Nephrology. PubMed ID: 31630709
[TBL] [Abstract][Full Text] [Related]
14. Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance.
Pochet JM; Bobrie G; Landais P; Goldfarb B; Grünfeld JP
Nephrol Dial Transplant; 1989; 4(12):1016-21. PubMed ID: 2517321
[TBL] [Abstract][Full Text] [Related]
15. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
[TBL] [Abstract][Full Text] [Related]
16. Hereditary abnormalities of renal basement membranes.
Savige J
Pathology; 1991 Oct; 23(4):350-5. PubMed ID: 1686082
[TBL] [Abstract][Full Text] [Related]
17. Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.
Frascà GM; Onetti-Muda A; Mari F; Longo I; Scala E; Pescucci C; Roccatello D; Alpa M; Coppo R; Li Volti G; Feriozzi S; Bergesio F; Schena FP; Renieri A;
Nephrol Dial Transplant; 2005 Mar; 20(3):545-51. PubMed ID: 15618242
[TBL] [Abstract][Full Text] [Related]
18. [Alport's syndrome: new findings].
García-Torres R; Orozco L
Bol Med Hosp Infant Mex; 1993 Aug; 50(8):596-602. PubMed ID: 8357522
[TBL] [Abstract][Full Text] [Related]
19. Alport's syndrome, Goodpasture's syndrome, and type IV collagen.
Hudson BG; Tryggvason K; Sundaramoorthy M; Neilson EG
N Engl J Med; 2003 Jun; 348(25):2543-56. PubMed ID: 12815141
[No Abstract] [Full Text] [Related]
20. Arteriovenous fistula aneurysms in patients with Alport's.
Field MA; McGrogan DG; Tullet K; Inston NG
J Vasc Access; 2013; 14(4):397-9. PubMed ID: 23817953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
